Plan ahead

Plan ahead of these events, and schedule time with us!

We can help you:

Understand

Understand the landscape in seconds for the targeted therapy of your choice.

Book a demo

To book a live demo to show you how this works specifically to your questions.

Events Beacon will be attending

13th World ADC San Diego 2022

September 6-9, 2022 | San Diego, USA

This September, Hanson Wade are excited to unite 600+ ADC enthusiasts and experts at the world’s definitive antibody-drug conjugate event.

The successes of 2021 are already being seen in 2022 with BLA submissions, more candidates entering the clinic, an ever-growing number of preclinical assets and positive results being shown in the subgroup of patients where previous treatments have failed – and the promise of ADCs to change the paradigm of oncology treatment is beginning to be realized. This meeting is designed to bring the community back-in person at the biggest and best event to date to help forward thinking researchers from biopharma advance the development of, and maximize, the clinical therapeutic index of ADCs.

Jia-He-Senior-ADC-Research-LeadBeacon’s own Jia He, Senior Research Lead for Beacon ADC, will be presenting at this global event, giving you the opportunity to see the power of Beacon Targeted Therapies ADC database solution. To view the full event guide click here.

You will also get the chance to meet the Beacon ADC team, see live demonstrations and ask questions about how Beacon ADC can give you the confidence to make faster and better decisions.

Register today to join us in San Diego this September.

To learn more about how Beacon’s ADC database solution can help you and your team click here.  

Find out more
World-ADC-San-Diego-2022-logo

13th World Multispecifics Summit 2022

September 20-22, 2022 | Boston, MA

The newly re-branded 13th World Multispecifics Summit returns this September as the only end-to-end meeting committed solely to advancing the development of bi- & multi-specific therapeutics.

This world-renowned forum will deliver a greater scope and penetration of innovative technical content than ever before. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field.

Whatever your role or interest, you will leave the meeting with concrete methods to employ in your strategy and pipeline to convert the promise of bi- and multi-specific therapeutics into a reality for patients.

Beacon Bispecific ResearcherBeacon’s own Shailee Patel, Research Analyst for the Beacon Bispecific module solution, will be opening day one of this global event by giving an enthralling lecture on The Landscape of Bi/Multispecifics and setting the scene for the rest of the expertly crafted agenda – download the full event guide here. You will get the chance to meet the Beacon Bispecific team, see live demonstrations and ask questions about how Beacon Bispecific can give you the confidence to make faster and better decisions.

Register today to join us in Boston this September.

To learn more about how Beacon’s Bispecific module solution can help you and your team click here.  

Find out more

Non-Small Cell Lung Cancer Drug Development Summit 2022

September 20-22, 2022 | Boston, MA

Despite the vast number of trials taking place within the NSCLC space, it remains one of the highest tumor indications of unmet clinical need, with prevalence only set to increase. Focusing from late-line through to early-line, this conference will address how to supercharge your pipeline through implementing smart drug design; expert translational medicine; advanced trial design and patient recruitment; and evidence-based combination and sequencing rationale specific to NSCLC.

There has never been a more important time to attend the 2nd NSCLC Drug Development Summit. Join this dedicated and determined community uniting to defeat NSCLC and radically change patients’ lives.

Beacon’s own Frank Plowden, Account Manager for Beacon Checkpoint, will be giving a lecture on The Difference a Decade Makes – The Rise of Checkpoint Inhibitors in Treating NSCLC in the morning of Day 1; giving you the opportunity to see the power and detail of Beacon Targeted Therapies data. View the full event guide here.

You will get the chance to meet the Beacon Checkpoint team, see live demonstrations and ask questions about how Beacon Checkpoint can give you the confidence to make faster and better decisions.

Register today to join us in Boston this September.

To learn more about how Beacon’s Checkpoint database solution can help you and your team click here.  

Find out more

7th Oncolytic Virotherapy Summit 2022

December 6-8, 2022 | Boston, MA

Navigate through Novel Viruses, Rational Combination Regimens, Optimized Virus Delivery & Clinical Grade Manufacturing to Make OV an Established Modality of Cancer Immunotherapy.

With rapid advances in this compelling  therapeutic, the 7th Virotherapy Summit returns to Boston this December. With IV-delivery now reaching the late preclinical stage, IT-delivery continuing to hold its ground within the clinic, and new combinations emerging there has never been a more exciting time for the oncolytic virotherapy community to come together.

Bringing together 100+ trailblazing biotech’s, pioneering large pharma, oncology-focused drug developers, VCs and financial investors to discuss:

  • Novel translational and combination data
  • CMC, Manufacturing & regulatory requirements
  • Partnering and licensing aspects
  • Optimizing both IV- and IT-based delivery

Join us at the world’s only true end-to-end OV summit as we finally realize the promise of oncolytic viruses.

Register today to join us in Boston this December.

Find out more

Conference Tracker

Upcoming events

Due to the impacts of COVID-19, we will be monitoring the activities of key conferences, to find out more about how we monitor this, please view our conference tracker.

Conference Tracker

logo